Disclosure of interest: Name of author: nothing to disclose Scientific Communications: imaging 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.07 - IMAGING - Non acute O - ESOC25-866 [18F]FEPPA-PET/MRI SHOWS CORRELATION OF CHRONIC NEUROINFLAMMATION AT 6 MONTHS AFTER ISCHEMIC STROKE WITH DEGRADATION IN MULTIPLE AND REMOTE WHITE MATTER PATHWAYS Stefan Poirier 1 , Rachel Wagner 2 , Linshan Liu 1 , Pavlo Ohorodnyk 3 , Michael Jurkiewicz 3 , Alexander Thiel 4 , Jonathan Thiessen 5 , Udunna Anazodo 6 , Alexander Khaw 7 1 Lawson Health Research Institute, Lawson Imaging, London, Canada, 2 Queen's University, School of Medicine, Kingston, Canada, 3 Western University, Schulich School of Medicine and Dentistry, Department of Medical Imaging, London, Canada, 4 McGill University, Jewish General Hospital, Department of Neurology and Neurosurgery, Montreal, Canada, 5 CancerCare Manitoba, Department of Medical Physics, Winnipeg, Canada, 6 McGill University, Montreal Neurological Institute, Department of Neurology and Neurosurgery, Montreal, Canada, 7 Western University, Schulich School of Medicine and Dentistry, Department of Clinical Neurological Sciences, London, Canada Background and Aims: The pathophysiological mechanisms linking chronic neuroinflammation, ischemic white matter (WM) injury, and post-stroke cognitive impairment (PSCI) are not well understood
Your health care provider needs to know if you have any of these conditions: kidney disease
But he also worries about the prospect of FDA leadership going against the advice of its own internal scientists
This includes nicotinamide riboside kinases, nicotinamide phosphoribosyltransferase, and other methyltransferases that could confound experimental results
